An influential U.S. senator has told a federal investigator that a University of Texas System researcher may not have properly disclosed her financial relationship with a drug company.
The inspector general at the U.S. Department of Health and Human Services could launch an inquiry into the scientist, UT child pharmacology researcher Karen Wagner.
The Dallas Morning News reports.
No comments:
Post a Comment